Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iPSC-derived neural stem/progenitor cell transplantation for subacute spinal cord injury
jRCTa031190228Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Dec 2021
- Countries
- 1
01
Overview
Open-label, single-arm trial in spinal cord injury (SCI), sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Safety. Started Dec 2021; status: completed.
02
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on jRCTa031190228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTa031190228.